Local effects of octreotide on glutamate-evoked activation of Adelta and C afferent fibers in rat hairy skin.
The aim of the present study was to investigate whether local application of octreotide, an analogue of somatostatin, suppresses the glutamate-evoked activities of Adelta and C primary afferent fibers innervating dorsal hairy skin of the rat in vivo. The single unit activity of Adelta and C afferent fibers was recorded in isolated filaments from the dorsal cutaneous branches of the T9-T12 spinal nerves. Changes in discharge relative to baseline during injection of glutamate (0.3mM, 10microL) into the receptive field with pretreatment by octreotide (20microM, 10microL) were compared with injection after pretreatment with normal saline. Most of Adelta fibers (21/27, 78%) and C fibers (21/26, 81%) in the dorsal cutaneous branches were significantly activated by local injection of glutamate following saline injection. The mean discharge rates increased from 2.39+/-0.30 and 2.42+/-0.37 impulses/min to 12.79+/-2.04 and 13.56+/-2.56 impulses/min during injection of glutamate for Adelta and C fibers, respectively. After octreotide pretreatment group, glutamate increased the mean discharge rates from 1.93+/-0.38 and 2.25+/-0.29 impulses/min to 6.11+/-0.9 and 6.31+/-1.18 impulses/min in Adelta fibers and C fibers, respectively. The discharge rates during injection of glutamate after octreotide pretreatment were significantly lower than after normal saline pretreatment. The suppressive effect of octreotide was reversed by the somatostatin receptor antagonist cyclo-somatostatin. These results suggest that interactions between excitatory amino acid and inhibitory neuropeptides may contribute to sensory signaling in the peripheral nervous system.
Luo
Rong
R
Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710061, PR China.
Guo
Yuan
Y
Cao
Dong-Yuan
DY
Pickar
Joel G
JG
Li
Li
L
Wang
Jun
J
Zhao
Yan
Y
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D004347:Drug Interactions / Q000502:physiology; D004594:Electrophysiology; D018698:Glutamic Acid / Q000378:metabolism / Q000494:pharmacology*; D018859:Hair Follicle / Q000294:innervation*; D009413:Nerve Fibers, Myelinated / Q000187:drug effects* / Q000378:metabolism; D036421:Nerve Fibers, Unmyelinated / Q000187:drug effects* / Q000378:metabolism; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D009619:Nociceptors / Q000187:drug effects / Q000378:metabolism; D015282:Octreotide / Q000494:pharmacology; D010146:Pain / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects / Q000502:physiology; D010812:Physical Stimulation; D051381:Rats; D017207:Rats, Sprague-Dawley; D017470:Receptors, Glutamate / Q000187:drug effects / Q000378:metabolism; D017481:Receptors, Somatostatin / Q000037:antagonists & inhibitors / Q000378:metabolism; D011984:Sensory Receptor Cells / Q000187:drug effects* / Q000378:metabolism; D012867:Skin / Q000294:innervation*; D013004:Somatostatin / Q000031:analogs & derivatives
D017470:Receptors, Glutamate; D017481:Receptors, Somatostatin; D018698:Glutamic Acid; D013004:Somatostatin; D015282:Octreotide